Overview
- 96 inspections across 81 sites are on record.
- 72 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-03-04.
At a glance
Inspections
96
Sites
81
Observations
72
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Spark Therapeutics, Inc. | 4 Mar 2022 | Biologics | On file |
| Grifols Diagnostic Solutions, Inc. | 7 Dec 2021 | Biologics | On file |
| Nelson Laboratories, LLC | 9 Nov 2021 | Biologics | |
| Janssen Pharmaceuticals Inc. | 17 Sep 2021 | Biologics | |
| Jubilant HollisterStier LLC | 31 Aug 2021 | Biologics | On file |
Sites inspected
Spark Therapeutics, Inc.Philadelphia, United States1 insp.
Grifols Diagnostic Solutions, Inc.Emeryville, United States1 insp.
Nelson Laboratories, LLCSalt Lake City, United States1 insp.
Janssen Pharmaceuticals Inc.Raritan, United States1 insp.
Jubilant HollisterStier LLCSpokane, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Paula A Trost15 shared
Burnell M Henry10 shared
Susan M Jackson10 shared
Jacqueline M Diaz Albertini7 shared
Prabhu P Raju4 shared
Simone E Pitts4 shared
Brentley S Collins3 shared
Mihaly S Ligmond3 shared
Christian Lynch3 shared
Steven E Bowen2 shared
Full investigator report
Get the verbatim findings behind Jacqueline M Diaz Albert's 72 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site